Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma

Published:2010-06 Issue:6 Volume:52 Page:872-879
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Kohga Keisuke,Tatsumi Tomohide,Takehara Tetsuo,Tsunematsu Hinako,Shimizu Satoshi,Yamamoto Masashi,Sasakawa Akira,Miyagi Takuya,Hayashi Norio

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan

Ministry of Health, Labour and Welfare of Japan

Publisher

Elsevier BV

Subject

Hepatology

Reference27 articles.

1. Hepatocellular carcinoma in cirrhosis: incidence and trends;Fattovich;Gastroenterology,2004

2. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients;Takayasu;Gastroenterology,2006

3. Biology of hepatocellular carcinoma;Pang;Ann Surg Oncol,2008

4. Recent advances in cancer stem cells;Cho;Curr Opin Genet Dev,2008

5. Cancer stem cell: target for anti-cancer therapy;Tang;FASEB J,2007

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression;Frontiers of Medicine;2024-04-11

2. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy;Frontiers in Immunology;2024-03-12

3. CD133 significance in glioblastoma development: in silico and in vitro study;European Journal of Medical Research;2024-03-06

4. Chimeric Antigen Receptor T Cell Therapy for Hepatocellular Carcinoma: Where Do We Stand?;International Journal of Molecular Sciences;2024-02-23

5. Advancements in Chimeric Antigen Receptor T Cell Therapy for Hepatocellular Carcinoma;E3S Web of Conferences;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3